Skip to main content
. 2022 Nov 10;2(11):1404–1417. doi: 10.1158/2767-9764.CRC-22-0266

FIGURE 7.

FIGURE 7

A model showing the mechanisms of action of antitumor combination effects from ZL-1201 in combination with therapeutic mAbs in the presence or absence of chemotherapy. (Created with BioRender.com)